Clinical Trials Browser

Phase 2/3 × Unknown × Thrombocytopenia × Clear all

NCT03701217 2018-10-09

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Phase 2/3 Unknown

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myeloid, Acute